Загрузка...
Evidence That Baseline Levels of Low-Density Lipoproteins Cholesterol Affect the Clinical Response of Graves’ Ophthalmopathy to Parenteral Corticosteroids
BACKGROUND: High dose intravenous glucocorticoid (ivGC) therapy is the first line treatment in moderate to severe Graves’ ophthalmopathy (GO) and is associated with a clinical response rate ranging from 50% to 80%. Recently, a positive correlation between total cholesterol and low-density lipoprotei...
Сохранить в:
| Опубликовано в: : | Front Endocrinol (Lausanne) |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7784376/ https://ncbi.nlm.nih.gov/pubmed/33414766 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.609895 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|